Literature DB >> 33594598

Gastric dysrhythmia in gastroesophageal reflux disease: a systematic review and meta-analysis.

Sameer Bhat1, Chris Varghese2, Daniel A Carson2, Tommy C L Hayes2, Armen A Gharibans2,3, Christopher N Andrews4, Gregory O'Grady2,3.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is a commonly diagnosed gastrointestinal disorder, with a substantial impact on the quality of life. The underlying pathophysiology of GERD is multifactorial and incompletely understood. Abnormal gastric electrical activity, measured using electrogastrography (EGG), may contribute. This study aimed to systematically review and meta-analyse the existing literature in which EGG was used in patients with GERD.
METHODS: Databases were systematically searched for studies using EGG in adults with GERD. The primary outcome was the percentage of recording time in the normogastric frequency range. Secondary outcomes were dominant frequency, dominant power, power ratio and prevalence of any EGG abnormality.
RESULTS: In total, 591 participants (427 patients with GERD; 164 healthy controls) from 13 studies were included. GERD patients spent 17.3% (SMD - 1.18, 95%CI: - 1.84, - 0.52) and 18.7% (SMD - 1.11, 95%CI: - 1.55, - 0.68) less of the preprandial and postprandial recording time in normogastric frequency ranges, respectively, compared to healthy controls. The dominant frequency, dominant power and power ratio were not significantly different to healthy controls in the preprandial and postprandial periods. The pooled prevalence of any EGG abnormality was significantly greater in patients with GERD than in healthy controls [46% (95%CI: 39-64%) vs. 10% (95%CI: 4-23%); p < 0.0001]. Correlations between GERD symptoms and EGG recordings were inconsistently studied. EGG techniques were heterogeneous.
CONCLUSIONS: Consistent abnormalities in gastric slow-wave activity, as measured by EGG, were identified in adults with GERD. Further investigation into these abnormalities using novel emerging electrophysiology techniques is desirable, to better define their contribution toward GERD pathophysiology.

Entities:  

Keywords:  Biomarker; Gastric electrical activity; Gastroesophageal reflux disorder; Heartburn; Slow wave

Mesh:

Year:  2021        PMID: 33594598     DOI: 10.1007/s10388-021-00820-6

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  31 in total

Review 1.  Therapeutic options for refractory gastroesophageal reflux disease.

Authors:  Ronnie Fass
Journal:  J Gastroenterol Hepatol       Date:  2012-04       Impact factor: 4.029

2.  Actionable biomarkers: the key to resolving disorders of gastrointestinal function.

Authors:  Michael Camilleri; Victor Chedid
Journal:  Gut       Date:  2020-04-08       Impact factor: 23.059

Review 3.  Esophageal Motility Disorders and Gastroesophageal Reflux Disease.

Authors:  Ravinder Mittal; Michael F Vaezi
Journal:  N Engl J Med       Date:  2020-11-12       Impact factor: 91.245

Review 4.  Presentation and Epidemiology of Gastroesophageal Reflux Disease.

Authors:  Joel E Richter; Joel H Rubenstein
Journal:  Gastroenterology       Date:  2017-08-03       Impact factor: 22.682

5.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

Review 6.  Gastroesophageal reflux disease: From pathophysiology to treatment.

Authors:  Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

7.  Spatial Patterns From High-Resolution Electrogastrography Correlate With Severity of Symptoms in Patients With Functional Dyspepsia and Gastroparesis.

Authors:  Armen A Gharibans; Todd P Coleman; Hayat Mousa; David C Kunkel
Journal:  Clin Gastroenterol Hepatol       Date:  2019-04-19       Impact factor: 11.382

Review 8.  Body surface mapping of the stomach: New directions for clinically evaluating gastric electrical activity.

Authors:  Daniel A Carson; Greg O'Grady; Peng Du; Armen A Gharibans; Christopher N Andrews
Journal:  Neurogastroenterol Motil       Date:  2020-12-04       Impact factor: 3.598

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Journal:  Health Qual Life Outcomes       Date:  2009-07-02       Impact factor: 3.186

View more
  2 in total

1.  Targeted ablation of gastric pacemaker sites to modulate patterns of bioelectrical slow wave activation and propagation in an anesthetized pig model.

Authors:  Zahra Aghababaie; Leo K Cheng; Niranchan Paskaranandavadivel; Recep Avci; Chih-Hsiang Alexander Chan; Ashton Matthee; Satya Amirapu; Samuel J Asirvatham; Gianrico Farrugia; Arthur Beyder; Gregory O'Grady; Timothy R Angeli-Gordon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-02-09       Impact factor: 4.052

2.  A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure.

Authors:  Carmelo Scarpignato; Eckhard Leifke; Neila Smith; Darcy J Mulford; Gezim Lahu; Axel Facius; Colin W Howden
Journal:  J Clin Pharmacol       Date:  2022-02-08       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.